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Abstract 
We report the case of an octagenerian who presented with leukocytoclastic vasculitis as 
the first symptom of Crohn’s disease. The patient was admitted with skin rash on the 
lower extremities and ankles and episodes of bloody diarrhea. Skin and colon biopsies 
revealed acute leukocytoclastic vasculitis and moderate Crohn’s disease, respectively. 
The patient was treated with intravenous corticosteroids in conjunction with antibiotics 
and per os mesalazine. Symptoms resolved rapidly within 5 days, and the patient was still 
asymptomatic on follow-up 3 months later. 
 
Introduction 
Extraintestinal manifestations of inflammatory bowel disease (IBD) can be found in 
21–36% of affected patients [1]. One third of these patients, preferably those with colonic 
involvement, reveal skin symptoms [2]. An increased variety of skin lesions usually 
develop during the course of the disease, while approximately 10% of IBD patients show 
cutaneous manifestations at the time of diagnosis. These are generally secondary to 
granulomatous cutaneous disease, reactive skin eruptions, nutritional deficiency and 
other associated conditions [3]. 
Apart from the most common cutaneous manifestations that develop in IBD, such as 
pyoderma gangrenosum (1–2%) and erythema nodosum (3–8%), leukocytoclastic 
vasculitis is one of the least reported skin lesions that seem to be linked to IBD [3]. 
Leukocytoclastic vasculitis is a disorder characterized by neutrophilic infiltration and 
nuclear debris in postcapillary venules [4] and it is believed that it is an immune complex  
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one [5]. The skin presentation of this type of vasculitis may vary from palpable purpura to 
necrotic ulcers. 
Here we report the case of an octagenerian who presented with leukocytoclastic 
vasculitis as the first symptom of Crohn’s disease (CD). We also review the literature for 
cases reporting an association between this type of vasculitis and IBD. 
Case Report 
An 80-year-old white male was initially admitted to the dermatology department complaining of 
skin rash on the lower extremities and ankles, nonspecific arthralgias and low-grade fever lasting for 
two months. A week before his admission, a corticosteroid cream had been applied for the skin rash 
without marked improvement. During his hospitalization he presented episodes of bloody diarrhea and 
he was transferred to our department in order to investigate the etiology of the diarrhea. 
His medical history included chronic obstructive pulmonary disease due to a left partial lobectomy 
(5 years earlier) and an amputated left arm due to a road traffic accident (10 years earlier). On 
admission he was hemodynamically stable and the low-grade fever (37.8°C) was confirmed. During 
physical examination a mild tenderness on the left lower quadrant was found. Skin examination 
revealed maculopapular purpura with areas of skin hyperpigmentation. On day one, the dermatologists 
performed a skin biopsy in order to clarify the nature of these lesions (differential diagnosis: 
hypersensitivity, allergic or leukocytoclastic or septic vasculitis). 
The first laboratory results in our ward were indicative of acute inflammation (elevated CRP, ESR, 
and fibrinogen). Complete blood count, urinalysis, biochemistry, and prothrombin time were normal. 
Stools, skin, and blood cultures were also negative. Fecal leukocytes and erythrocytes were noted on 
microscopic examination of the stools and therefore serum antibodies against Yersinia 
pseudotuberculosis and Yersinia enterocolitica were examined. The results revealed an old infection. The 
complement components C3, C4, serum immunoglobulin electrophoresis, and cancer markers were 
normal; Rose-Bengal, Wright, rheumatoid factor, cryobulins, ANA, anti-DNA, ANCA, and PPD test 
were negative. Hepatitis B and C virus markers were absent. Plain abdominal X-ray was normal. 
Abdominal ultrasound showed thickening of the intestinal loops and lack of peristalsis. Thus an 
emergency colonoscopy was carried out. A punctuate congested mucosa with superficial ulceration was 
observed and five biopsy specimens were taken. 
Five days after admission, skin and colon biopsies revealed acute leukocytoclastic vasculitis 
(neutrophilic infiltration, necrosis of vessel wall, perivascular fibrinoid deposition) (fig. 1) and 
moderate CD (cryptitis – crypt absesses), respectively. Therefore the patient received corticosteroids 
(50 mg i.v. prednisolone) in conjunction with antibiotics (500 mg i.v. ciprofloxacin bid) and per os 
mesalazine (500 mg tid). Five days after treatment administration, the diarrhea subsided and the skin 
rash disappeared. He was discharged with per os 30 mg prednisolone (on a slow tapering rate) and 
500 mg tid mesalazine. On follow-up 3 months later, the patient was only on mesalazine and 
asymptomatic. 
Discussion 
Leukocytoclastic vasculitis is a form of vasculitis affecting postcapillary venules with 
the histopathological findings of endothelial swelling, neutrophilic invasion of blood 
vessel walls, leukocytoclasis (karyorrhexis of nuclei of neutrophils), extravasation of 
erythrocytes and fibrinoid necrosis of blood vessel walls [4]. It appears on the skin of 
dependent sites as crops of palpable purpura and is mostly mediated by deposition of 
immune complexes in postcapillary venules (immune complex vasculitis of small vessels). 
In the majority of patients the precipitating cause is unidentifiable, but association with 
drugs, infections (e.g. hepatitis B) or immune complex diseases (e.g. collagen vascular 
diseases, cancer) should be first excluded [5].  
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The pathogenetic mechanisms underlying leukocytoclastic vasculitis in patients with 
IBD remain still unclear. Direct colonic bacterial dissemination of the skin via a 
hematogeneous pathway could explain the onset of skin lesions with the exacerbation 
and/or onset of active bowel disease. In genetically predisposed IBD patients, alternate 
pathophysiological mechanisms including the mechanism of immune complex formation 
in the axis of the inflamed mucosal barrier-immunity [6] and the mechanisms of ‘antigen 
mimicry’ [7] could be suggested. The former mechanism is frequently revealed by direct 
immunofluorescence of early lesions by the presence of IgM, IgG and C3 within the walls 
of small vessels in the upper dermis [8, 9]. On the other hand, the antigen mimicry as a 
modified immune response to bacteria or other local factors may trigger the activation of 
T-cell-mediated injury (proinflammatory cytokines) and the secretion of autoantibodies 
against shared antigens. In this connection a colonic epithelial protein and the human 
tropomyosin isoform 5, which are shared by different extraintestinal sites including the 
skin, seem to be the most important targets of the autoimmune attack [10]. 
Reviewing the literature, four reports of leukocytoclastic vasculitis (based on a detailed 
histopathological diagnosis) in association with CD have been found [11–14]. In two of 
them there was a correlation between the onset of vasculitis and the exacerbation of CD 
[11, 13], whereas no association was found in the other two cases. To our knowledge, this 
is the first case reporting leukocytoclastic vasculitis as the initial manifestation of CD. It is 
apparent that this skin manifestation antedates the onset of CD, although in all the 
aforementioned cases CD preceded the occurrence of vasculitis. There was no need for 
specific therapy as the therapeutic management of the underlying CD resulted in 
resolution of the vasculitis. 
Four additional patients with CD have been reported with cutaneous vasculitis of 
presumed leukocytoclastic type as there was no histological confirmation [15–17]. Among 
these cases, there was a female pediatric patient who was diagnosed with cutaneous 
vasculitis secondary to septic thromboembolism as the first symptom of her CD. This skin 
lesion resolved simultaneously with the resolution of the flare of the CD [17]. 
Apart from CD, leukocytoclastic vasculitis has also been reported in four patients with 
ulcerative colitis. In these cases, the cutaneous lesions always preceded the intestinal 
symptoms with different lag periods, in contrast to CD, where the extraintestinal 
cutaneous manifestations appear not only as onset symptoms but also during 
exacerbation periods of the disease [18–20]. 
In conclusion, we report the case of an elderly patient who presented with 
leukocytoclastic vasculitis as the first symptom of CD. Although the pathophysiological 
mechanisms of this rare skin complication are unclear, we observed that the lesion 
resolved after treatment of the underlying disease. 
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Fig. 1. Pathology examination: skin biopsies showed neutrophilic infiltration, necrosis of vessel wall 
and perivascular fibrinoid deposition (acute leukocytoclastic vasculitis). 
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